ELAN vs SMMT: stock comparison and AI forecast
Elanco Animal Health Inc (ELAN) and Summit Therapeutics Inc. (SMMT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ELAN Elanco Animal Health Inc
- Price
- $24.57 +6.9% · 6M
- Market Cap
- $12.28B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
SMMT Summit Therapeutics Inc.
- Price
- $14.80 -12.8% · 6M
- Market Cap
- $12.60B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ELAN and SMMT have similar market capitalizations ($12.28B and $12.60B).
- Over the last six months ELAN returned +6.9% and SMMT -12.8%.
- ELAN carries 1.06 times debt per unit of equity, against 0.19 times for SMMT.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ELAN | SMMT |
|---|---|---|
| Market Cap | $12.28B | $12.60B |
| P/B Ratio | 1.86x | 20.01x |
| EPS | $-0.38 | $-0.96 |
| Book Value/Share | $13.19 | $0.79 |
| Revenue/Share | $10.05 | – |
| FCF/Share | $0.76 | $-0.58 |
Profitability & Margins
| Metric | ELAN | SMMT |
|---|---|---|
| ROE | -3.0% | -135.9% |
| ROA | -1.5% | -113.8% |
| Gross Margin | 55.4% | – |
| Net Margin | -4.0% | – |
| EBT Margin | -3.3% | – |
| Tax Rate | -19.9% | 0.0% |
Financial Health
| Metric | ELAN | SMMT |
|---|---|---|
| Current Ratio | 2.05x | 6.96x |
| Quick Ratio | 1.10x | – |
| D/E Ratio | 1.06x | 0.19x |
| Financial Leverage | 2.06x | 1.19x |
| Interest Coverage | – | -512.6x |
| Working Capital | $1.95B | $617M |
Cash Flow
| Metric | ELAN | SMMT |
|---|---|---|
| Operating Cash Flow | $617M | -$458M |
| Free Cash Flow | $379M | -$460M |
| Capital Spending | -$238M | -$1M |
| OCF Growth YoY | 7.9% | – |
| FCF Growth YoY | 5.0% | – |
| FCF/Sales | 7.5% | – |
| CapEx/Sales | 4.7% | – |
Operational Efficiency
| Metric | ELAN | SMMT |
|---|---|---|
| Asset Turnover | 0.37x | – |
| Receivables Turnover | 4.7x | – |
| Inventory Turnover | 1.3x | – |
| Fixed Assets Turnover | 3.6x | – |
| Days Sales Outstanding | 78 days | – |
| Days Inventory | 288 days | – |
| Payables Period | 70 days | – |
| Cash Conversion Cycle | 297 days | – |
Income Statement
| Metric | ELAN | SMMT |
|---|---|---|
| Total Revenue | $5.02B | – |
| Net Income | -$199M | -$856M |
| R&D Expense | $371M | $569M |
| SG&A Expense | $1.52B | – |
| Cost of Goods Sold | $2.24B | – |
Dividend & Shareholder Information
| Metric | ELAN | SMMT |
|---|---|---|
| Shares Outstanding | 500M | 798M |
| Net Income Growth | -145.8% | – |
| EPS Growth | -147.5% | – |
ELAN vs SMMT: stock comparison and AI forecast
Which is bigger, ELAN or SMMT?
ELAN and SMMT have similar market capitalizations ($12.28B and $12.60B).
Which stock performed better over the last six months, ELAN or SMMT?
Over the last six months ELAN returned +6.9% and SMMT -12.8%.
Which one does Intratio's AI model rank higher, ELAN or SMMT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.